$1.68
4.55% yesterday
Nasdaq, Sep 23, 10:15 pm CET

BioNano Genomics, Inc. Stock price

$1.68
-2.42 59.02% 1M
-1.62 49.09% 6M
-15.62 90.29% YTD
-22.32 93.00% 1Y
-1,114.32 99.85% 3Y
-351.66 99.52% 5Y
-4,192.32 99.96% 10Y
-4,192.32 99.96% 20Y
Nasdaq, Closing price Tue, Sep 23 2025
-0.08 4.55%

Key metrics

Basic
Market capitalization
$16.3m
Enterprise Value
$3.6m
Net debt
positive
Cash
$16.4m
Shares outstanding
3.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.6 | 0.6
EV/Sales
0.1 | 0.2
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
46.1%
Return on Equity
-316.7%
ROCE
-97.8%
ROIC
-127.4%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$27.4m | $28.7m
EBITDA
$-37.7m | $-13.6m
EBIT
$-50.7m | $-32.3m
Net Income
$-74.3m | $-29.0m
Free Cash Flow
$-26.1m
Growth (TTM | estimate)
Revenue
-25.0% | -6.8%
EBITDA
58.1% | 80.5%
EBIT
50.9% | 57.6%
Net Income
63.6% | 74.1%
Free Cash Flow
75.4%
Margin (TTM | estimate)
Gross
5.1%
EBITDA
-137.3% | -47.5%
EBIT
-184.8%
Net
-271.0% | -101.2%
Free Cash Flow
-95.0%
More
EPS
$-21.6
FCF per Share
$-6.7
Short interest
7.1%
Employees
99
Rev per Employee
$310.0k
Show more

Is BioNano Genomics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

BioNano Genomics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a BioNano Genomics, Inc. forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a BioNano Genomics, Inc. forecast:

Buy
78%
Hold
22%

Financial data from BioNano Genomics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
27 27
25% 25%
100%
- Direct Costs 26 26
0% 0%
95%
1.39 1.39
87% 87%
5%
- Selling and Administrative Expenses 39 39
46% 46%
141%
- Research and Development Expense 13 13
68% 68%
49%
-38 -38
58% 58%
-137%
- Depreciation and Amortization 13 13
3% 3%
48%
EBIT (Operating Income) EBIT -51 -51
51% 51%
-185%
Net Profit -74 -74
64% 64%
-271%

In millions USD.

Don't miss a Thing! We will send you all news about BioNano Genomics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioNano Genomics, Inc. Stock News

Neutral
GlobeNewsWire
6 days ago
SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the closing of its previously announced public offering of an aggregate of 5,000,000 shares of the Company's common stock (or common stock equivalents in lieu thereof), Series E warrants to purchase up to 5,000,000 shares of the Company's common stock and short-term S...
Neutral
GlobeNewsWire
8 days ago
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement known as chromoanagenesis was published with multiple studies highlighting the advantages of optical genome mapping (OGM) in chromoanagenesis research.
Neutral
GlobeNewsWire
9 days ago
SAN DIEGO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that Centers for Medicare & Medicaid Services (CMS) posted the preliminary payment determination for the Category I Current Procedural Terminology (C...
More BioNano Genomics, Inc. News

Company Profile

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Head office United States
CEO Robert Holmlin
Employees 99
Founded 2003
Website bionano.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today